+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Asia - Pacific Advanced Wound Care Market by Product, Application, and End User: Opportunity Analysis and Industry Forecast, 2018 - 2025

  • ID: 4656196
  • Report
  • Region: Asia
  • 150 pages
  • Allied Analytics LLP
1 of 4
The Asia-Pacific advanced wound care (AWC) market was valued at $1,658 million in 2017, and is projected to reach $3,655 million by 2025, registering a CAGR of 10.4% during the forecast period. Advanced wound care is a therapeutic approach that provides a moist microenvironment to stimulate the natural healing process. These products are mainly used to treat and manage complex wounds, such as burns, complex trauma, chronic wounds, and surgical wounds. Due to its efficacy and use in managing wounds, advanced wound care has emerged as a standard solution for treating chronic wounds and is replacing traditional wound care products.

The growth of the market is attributed to the rapid increase in prevalence of chronic diseases such as diabetes, favorable reimbursement scenario in developed countries, and rise in inclination toward wound care products that enhance therapeutic outcomes. Other factors such as changes in lifestyles, increase in healthcare expenditure by the government, and attempts to minimize surgical costs by reducing the duration of hospital stays drive the growth of the advanced wound care market. However, high cost of advanced wound care products and low awareness, especially in the under-developed countries are the factors expected to restrain the market growth.

This report categorizes the Asia-Pacific advanced wound care market based on product type, application, end user, and region. By product type, the market is divided into infection management, exudate management, active wound care, and therapy devices. Infection management is the leading segment in the product type and is further sub-segmented into silver dressing, non-silver dressing, and collagen. Based on application, the market is bifurcated into chronic wound care and acute wound care. Based on end user, the market is categorized into hospital and community health service centers. Based on country, the market is studied across Singapore, Malaysia, Japan, China, India, South Korea, Australia, and rest of Asia-Pacific.

Key Market Benefits For Asia-Pacific Advanced Wound Care:
  • This report offers a detailed quantitative analysis of the current market trends from 2014 to 2025 to identify the prevailing opportunities. The market forecast and opportunities have been provided from 2018 to 2025.
  • The market estimations provided in this report are based on a comprehensive analysis of the key developments in the industry.
  • In-depth analysis based on country helps understand the regional market to assist in strategic business planning.
  • The development strategies adopted by key manufacturers are enlisted in the report to understand the competitive scenario of the market.
Asia-Pacific Advanced Wound Care Market Market Segements:

By Product
  • Infection Management
  • Silver Wound Dressing
  • Non-silver Dressing
  • Collagen
  • Exudate Management
  • Hydrocolloid
  • Foam Dressing
  • Alginate
  • Hydrogel
  • Active Wound Care
  • Skin Substitute
  • Growth Factor
  • Therapy Device
  • Negative Pressure Wound Therapy
  • Oxygen and Hyperbaric Oxygen Equipment
  • Electromagnetic Therapy Device
  • Others
By Application
  • Chronic Wound Care
  • Pressure Ulcer
  • Diabetic Foot Ulcer
  • Venous Leg Ulcer
  • Arterial Ulcer
  • Acute Wound Care
  • Burns & Trauma
  • Surgical Wound
By End User
  • Hospital
  • Community Health Service Center
By Country
  • Singapore
  • Malaysia
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Rest of Asia-Pacific
KEY PLAYERS PROFILED
  • 3M Company
  • Smith & Nephew Plc
  • Coloplast A/S
  • Medtronic Plc
  • Acelity L.P. Inc.
  • Cardinal Health, Inc.
  • Mölnlycke
  • ConvaTec Group Plc
  • Essity Aktiebolag (BSN Medical GmbH)
  • B. Braun Melsungen AG
The other players of the Asia-Pacific advanced wound care market include (companies not profiled in the report):
  • Hollister Incorporated
  • Medline Industries, Inc.
  • Johnson & Johnson
  • Baxter International
  • Triage Meditech
  • Integra Lifesciences
  • Derma Sciences Inc.
Note: Product cover images may vary from those shown
2 of 4
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top investment pockets
3.3. Porters Five Forces analysis
3.4. Market Share Analysis
3.5. Market Dynamics
3.5.1. Drivers
3.5.1.1. Rapidly aging population and favorable demographics
3.5.1.2. Technological advancements to deal with complex wounds
3.5.1.3. Increased awareness to reduce healthcare costs
3.5.2. Restrains
3.5.2.1. Reluctance in adoption of new technologies
3.5.2.2. Development of substitute products and lack of sufficient evidence
3.5.3. Opportunities
3.5.3.1. Increased focus toward advanced treatment protocols
3.5.3.2. Significant unmet need in wound care

CHAPTER 4: ASIA-PACIFIC ADVANCED WOUND CARE MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast, by product
4.2. Infection Management
4.2.1. Key market trends and growth opportunities
4.2.2. Market size and forecast, by type
4.2.3. Silver wound dressings
4.2.3.1. Market size and forecast
4.2.4. Non-silver dressings
4.2.4.1. Market size and forecast
4.2.5. Collagen dressings
4.2.5.1. Market size and forecast
4.3. Exudate Management
4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast, by type
4.3.3. Hydrocolloid dressings
4.3.3.1. Market size and forecast
4.3.4. Foam dressings
4.3.4.1. Market size and forecast
4.3.5. Alginate dressings
4.3.5.1. Market size and forecast
4.3.6. Hydrogel dressings
4.3.6.1. Market size and forecast
4.4. Active Wound Care
4.4.1. Key market trends and opportunities
4.4.2. Market size and forecast, by type
4.4.3. Skin substitutes
4.4.3.1. Market size and forecast
4.4.4. Growth factors
4.4.4.1. Market size and forecast
4.5. Therapy Devices
4.5.1. Key market trends and opportunities
4.5.2. Market size and forecast, by type
4.5.3. Negative pressure wound therapy (NPWT)
4.5.3.1. Market size and forecast
4.5.4. Oxygen and hyperbaric oxygen equipment
4.5.4.1. Market size and forecast
4.5.5. Electromagnetic therapy devices
4.5.5.1. Market size and forecast
4.5.6. Others
4.5.6.1. Market size and forecast

CHAPTER 5: ASIA-PACIFIC ADVANCED WOUND CARE MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast, by application
5.2. Chronic Wounds
5.2.1. Market size and forecast, by type
5.2.2. Pressure ulcers
5.2.2.1. Market size and forecast
5.2.3. Diabetic foot ulcers
5.2.3.1. Market size and forecast
5.2.4. Venous leg ulcers
5.2.4.1. Market size and forecast
5.2.5. Arterial ulcers
5.2.5.1. Market size and forecast
5.3. Acute Wounds
5.3.1. Key market trends and growth opportunities
5.3.2. Market size and forecast, by type
5.3.3. Burns and trauma
5.3.3.1. Market size and forecast
5.3.4. Surgical wounds
5.3.4.1. Market size and forecast

CHAPTER 6: ASIA-PACIFIC ADVANCED WOUND CARE MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast, by end user
6.2. Hospitals
6.2.1. Market size and forecast
6.3. Community Health Service Centers
6.3.1. Market size and forecast

CHAPTER 7: ASIA-PACIFIC ADVANCED WOUND CARE MARKET, BY COUNTRY
7.1. Overview
7.1.1. Market size and forecast, by country
7.2. Singapore
7.2.1. Market size and forecast
7.3. Malaysia
7.3.1. Market size and forecast
7.4. Japan
7.4.1. Market size and forecast
7.5. China
7.5.1. Market size and forecast
7.6. India
7.6.1. Market size and forecast
7.7. South Korea
7.7.1. Market size and forecast
7.8. Australia
7.8.1. Market size and forecast
7.9. Rest of Asia-Pacific
7.9.1. Market size and forecast

CHAPTER 8: COMPANY PROFILES
8.1. 3M Company
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.2. Acelity L.P. Inc.
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.2.6. Key strategic moves and developments
8.3. B. Braun Melsungen AG
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.3.6. Key strategic moves and developments
8.4. Cardinal Health, Inc.
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.5. Coloplast A/S
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.6. ConvaTec Group Plc
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.7. Essity Aktiebolag (BSN Medical GmbH)
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Product portfolio
8.7.4. Business performance
8.8. Medtronic Plc. (Covidien Ltd.)
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.9. Mlnlycke Health Care AB
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.10. Smith & Nephew Plc.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
According to a new report titled, Asia-Pacific Advanced Wound Care Market by Product, Application, End User, and Country: Opportunity Analysis and Industry Forecast, 2018-2025, the Asia-Pacific advanced wound care (AWC) market accounted for $1,658 million in 2017, and is expected to reach $3,655 million by 2025, growing at a CAGR of 10.4% from 2018 to 2025. Japan was the highest contributor in the Asia-Pacific advanced wound care market in 2017, whereas, China is expected to witness the highest growth rate during the forecast period.

The therapy device segment was the highest revenue contributor in 2017. Advanced wound care therapies are specialized treatments for chronic or non-healing wounds and are majorly opted when standard wound care has failed. Advanced wound care products mainly focus on maintaining a stable temperature around the wound, protecting the wound from infection, relieving pain while changing dressing, facilitating oxygen flow, and removing dead tissue to prevent scarring and thus, allow new cells to emerge.

The major factors that boost the market growth include changes in lifestyles that lead to increased diabetic wounds, pressure ulcers, and technological advancements followed by favorable reimbursement scenario, and increase in adoption rates for these products. In addition, presence of high unmet medical needs and rise in preference for products that enhance therapeutic outcome are anticipated to drive the demand for advanced wound care devices. However, high cost of advanced wound care products and unfavorable reimbursement policies in the emerging countries are some of the factors that restrict the market growth.

Based on product type, the active wound care segment is the most lucrative market, growing at a high CAGR. This is attributed to the low toxicity and biocompatibility characteristics of the products and increase in incidence of chronic diseases such as diabetes.

Based on end user, the community health service centers segment is the major contributor toward the Asia-Pacific AWC market in 2017 and is projected to maintain the same trend throughout the forecast period. The rise can be attributed to the increase in the adoption rate of high technology solutions and the availability of wide range of AWC products under one roof coupled with government reimbursements.

Key Findings of the Study

Chronic wounds segment is projected to grow at the highest rate during the analysis period.
Japan dominated the Asia-Pacific advanced wound care market in 2017 and is projected to continue its dominance in future.
Growth factor segment is expected to experience high growth in the Asia-Pacific region during the forecast period.
Exudate management segment was the largest contributor toward the Asia-Pacific AWC market in 2017 and is projected to continue its dominance in future.
Diabetic foot ulcers segment generated the highest revenue and is expected to continue its dominance in future.

The key players profiled in the report include 3M Company, Smith & Nephew plc, Coloplast A/S, Medtronic plc, Acelity L.P. Inc., Cardinal Health, Inc., ConvaTec Group Plc, Essity Aktiebolag (BSN Medical GmbH), B. Braun Melsungen AG, and Mlnlycke Health Care AB.Other prominent players in the value chain include Hollister Incorporated, Medline Industries, Inc., Johnson & Johnson, Baxter International, Triage Meditech, Integra Lifesciences, and Derma Sciences Inc.
Note: Product cover images may vary from those shown
5 of 4

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Adroll
adroll